Pharmaceuticals

Premium

Healthcare

28 June, 2024

Morocco's Laprophan Group set to acquire local natural food supplement brand

Moroccan pharmaceuticals major The Laprophan Group is set to acquire a majority stake in a natural food supplement company to ......

Premium

Healthcare

27 June, 2024

Searchlight: MSN Labs gunning for growth in FY25 with diversification plans

MSN Laboratories Pvt. Ltd, a Hyderabad-based drugmaker focused on active pharmaceutical ingredients (APIs) and finished dosages, is aiming to foray ......

Healthcare

13 June, 2024

Suven Pharma to acquire majority stake in Sapala Organics for $27 mn

Private equity giant Advent-owned contract development and manufacturing organization (CDMO) Suven Pharma has entered into a definitive agreement to acquire ......

Premium

Healthcare

06 June, 2024

Can Bioplus bounce back from revenue stagnation after PE investor's exit?

Healthcare supplements maker Bioplus Life Sciences Pvt. Ltd, which was a portfolio company for Asia-focused private equity firm AIF Capital ......

Healthcare

31 May, 2024

Tata Capital Healthcare Fund backs Orbicular in fresh pharma bet

Growth-focused private equity fund Tata Capital Healthcare Fund II has invested $20 million (around Rs 167 crore) Hyderabad-based specialty pharma ......

Premium

Healthcare

27 May, 2024

Searchlight: Emnar Pharma poised to turn around after a decline in FY23 financials

Emnar Pharma Pvt. Ltd (formerly Emmennar Pharma), a part of the Virchow group, is likely to see a rebound in ......

Pro

Healthcare

16 May, 2024

ADIA joining cap table of Indian pharmaceutical platform

Abu Dhabi Investment Authority (ADIA), one of the most active sovereign funds operating in India striking both private equity style ......

Premium

Healthcare

15 May, 2024

Bottomline: How PlasmaGen Bio plans to break its streak of revenue stagnancy

Bengaluru-based biopharmaceutical company PlasmaGen Biosciences Pvt. Ltd, backed by venture capital firm Eight Roads Ventures, is poised to break out ......

Premium

Healthcare

30 April, 2024

Exclusive: Advent's healthcare investment platform mulls betting on south Indian API maker

Advent, one of the world’s biggest private equity players, is evaluating an investment in a Chennai-based active pharmaceutical ingredient (API) ......

Premium

Healthcare

25 April, 2024

Searchlight: TCG Lifesciences' topline may take hit on slowing ops in subsidiaries

TCG Lifesciences Pvt. Ltd, a part of The Chatterjee Group, may record a weaker performance for the year ended March ......